OpenURL Connection Search

Select item for more details and to access through your institution.

Pharmacokinetics and pharmacodynamics of a single dose Nilotinib in individuals with Parkinson's disease.
Published in:
Pharmacology Research & Perspectives, 2019, v. 7, n. 2, p. 1, doi. 10.1002/prp2.470
By:
- Pagan, Fernando L.;
- Hebron, Michaeline L.;
- Wilmarth, Barbara;
- Torres-Yaghi, Yasar;
- Lawler, Abigail;
- Mundel, Elizabeth E.;
- Yusuf, Nadia;
- Starr, Nathan J.;
- Arellano, Joy;
- Howard, Helen H.;
- Peyton, Margo;
- Matar, Sara;
- Liu, Xiaoguang;
- Fowler, Alan J.;
- Schwartz, Sorell L.;
- Ahn, Jaeil;
- Moussa, Charbel
Publication type:
Article
Nilotinib effects on safety, tolerability, and biomarkers in Alzheimer's disease: A phase 2, double‐blind, randomized, placebo‐controlled trial: Human/Human trials: Anti‐amyloid.
Published in:
Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.044628
By:
- Turner, Raymond Scott;
- Hebron, Michaeline;
- Lawler, Abigail;
- Mundel, Elizabeth;
- Yusuf, Nadia;
- Starr, Nathan;
- Pagan, Fernando;
- Torres‐Yaghi, Yasar;
- Shi, Wangke;
- Mulki, Sanjana;
- Ferrante, Dalila;
- Matar, Sara;
- Liu, Xiaoguang;
- Esposito, Guiseppe;
- Berkowitz, Frank;
- Jiang, Xiong;
- Ahn, Jaeil;
- Moussa, Charbel E‐H
Publication type:
Article
Nilotinib Effects on Safety, Tolerability, and Potential Biomarkers in Parkinson Disease: A Phase 2 Randomized Clinical Trial.
Published in:
JAMA Neurology, 2020, v. 77, n. 3, p. 309, doi. 10.1001/jamaneurol.2019.4200
By:
- Pagan, Fernando. L.;
- Hebron, Michaeline L.;
- Wilmarth, Barbara;
- Torres-Yaghi, Yasar;
- Lawler, Abigail;
- Mundel, Elizabeth E.;
- Yusuf, Nadia;
- Starr, Nathan J.;
- Anjum, Muhammad;
- Arellano, Joy;
- Howard, Helen H.;
- Shi, Wangke;
- Mulki, Sanjana;
- Kurd-Misto, Tarick;
- Matar, Sara;
- Liu, Xiaoguang;
- Ahn, Jaeil;
- Moussa, Charbel
Publication type:
Article
Nilotinib Effects on Safety, Tolerability, and Biomarkers in Alzheimer's Disease.
Published in:
2020
By:
- Turner, Raymond S.;
- Hebron, Michaeline L.;
- Lawler, Abigail;
- Mundel, Elizabeth E.;
- Yusuf, Nadia;
- Starr, J. Nathan;
- Anjum, Muhammad;
- Pagan, Fernando;
- Torres‐Yaghi, Yasar;
- Shi, Wangke;
- Mulki, Sanjana;
- Ferrante, Dalila;
- Matar, Sara;
- Liu, Xiaoguang;
- Esposito, Giuseppe;
- Berkowitz, Frank;
- Jiang, Xiong;
- Ahn, Jaeil;
- Moussa, Charbel;
- Torres-Yaghi, Yasar
Publication type:
journal article

Found: 4

Pharmacokinetics and pharmacodynamics of a single dose Nilotinib in individuals with Parkinson's disease.

Nilotinib effects on safety, tolerability, and biomarkers in Alzheimer's disease: A phase 2, double‐blind, randomized, placebo‐controlled trial: Human/Human trials: Anti‐amyloid.

Nilotinib Effects on Safety, Tolerability, and Potential Biomarkers in Parkinson Disease: A Phase 2 Randomized Clinical Trial.

Nilotinib Effects on Safety, Tolerability, and Biomarkers in Alzheimer's Disease.